Neurogastrx is a biopharmaceutical company developing products for the treatment gastrointestinal disorders treatment. Its lead product is under development for the treatment of gastroparesis, a debilitating condition caused by abnormal gastric function.
|HQ||Woburn, MA, US||Map|
|Employees (est.) (Oct 2021)||11||(+10%)|
Neurogastrx total Funding
Neurogastrx latest funding size
Time since last funding
|4 years ago|
|5AM Ventures, OrbiMed, venBio Partners|
When was Neurogastrx founded?
Neurogastrx was founded in 2012.
Who are Neurogastrx key executives?
Neurogastrx's key executives are Klaus Veitinger, Jim O'Mara and David Allison.
How many employees does Neurogastrx have?
Neurogastrx has 11 employees.
Who are Neurogastrx competitors?
Competitors of Neurogastrx include Alexion Pharmaceuticals, KiOmed Pharma and CorMedix.
Where is Neurogastrx headquarters?
Neurogastrx headquarters is located at 60 Unicorn Park Dr, Woburn.
Where are Neurogastrx offices?
Neurogastrx has an office in Woburn.
How many offices does Neurogastrx have?
Neurogastrx has 1 office.
Receive alerts for 300+ data fields across thousands of companies